Kenya is set to benefit from the United Kingdom’s genomic sequencing support as the country intensifies the fight against Covid-19. Through the UK’s New Variant Assessment Platform Programme, the Kenya Medical Research Institute (Kemri) will have access to the UK unique sequencing and variant assessment capabilities. "I welcome this partnership with Kenya, to identify, track and respond to new Covid-19 variants and future health threats. The genomic sequencing support includes; reagents and equipment to increase in-country sequencing, technical advice, bioinformatics support and training. Genomic sequencing analyses the virus sample is taken from a diagnosed patient and compares it with other cases.

Source: The Star July 08, 2021 12:00 UTC